Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Long intergenic non-protein coding RNA 939 (LINC00939)** is a long intergenic non-coding RNA (lincRNA), a class of RNA molecules longer than 200 nucleotides that do not overlap known protein-coding genes[1][3][7]. LincRNAs function primarily at the RNA level and are not translated into protein. As a lincRNA, LINC00939 is transcribed but does not encode a functional protein. General functions of lincRNAs include gene expression regulation, chromatin and genome architecture remodeling, transcriptional regulation, RNA stabilization, and sometimes roles associated with enhancer activity[3][5]. While many lincRNAs have been found to regulate gene expression in cis (nearby genes) or in trans (distant genes), and some have disease relevance or act as disease biomarkers, the specific function and disease associations for LINC00939 remain poorly characterized in the current literature. No drugs are known to target LINC00939, and it is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 939 (LINC00939).